Cloverleaf Bio

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Third Arc Bio

This biotechnology company develops multifunctional antibodies to treat solid tumours and inflammatory diseases for the healthcare sector.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

Rezo Therapeutics

This biotechnology company develops drug discovery platforms and targeted therapies for oncology and other serious diseases, serving the pharmaceutical and healthcare industries.

Eigen Therapeutics

The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

Flamingo Therapeutics

This biotechnology company develops RNA-targeted therapies to treat various forms of cancer for patients with solid tumours.